Max Health™ is pleased to announce the advice received from Medsafe, that effective 19/03/2015, Neostigmine injection has been registered for use in New Zealand. This product is manufactured in Europe and supplied to Max Health™ by Hameln Plus.
Max Health™ is pleased to announce the advice received from Medsafe, that effective 19/03/2015, Neostigmine injection has been registered for use in New Zealand. This product is manufactured in Europe and supplied to Max Health™ by Hameln Plus.